GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OTCPK:KARBF) » Definitions » Cyclically Adjusted FCF per Share

Karo Pharma AB (Karo Pharma AB) Cyclically Adjusted FCF per Share : $0.00 (As of Jun. 2022)


View and export this data going back to . Start your Free Trial

What is Karo Pharma AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Karo Pharma AB's adjusted free cash flow per share for the three months ended in Jun. 2022 was $0.000. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Jun. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-07), Karo Pharma AB's current stock price is $5.25. Karo Pharma AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2022 was $0.00. Karo Pharma AB's Cyclically Adjusted Price-to-FCF of today is .


Karo Pharma AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Karo Pharma AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karo Pharma AB Cyclically Adjusted FCF per Share Chart

Karo Pharma AB Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Karo Pharma AB Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Karo Pharma AB's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Karo Pharma AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Karo Pharma AB's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Karo Pharma AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Karo Pharma AB's Cyclically Adjusted Price-to-FCF falls into.



Karo Pharma AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Karo Pharma AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2022 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2022 (Change)*Current CPI (Jun. 2022)
=0/118.3836*118.3836
=0.000

Current CPI (Jun. 2022) = 118.3836.

Karo Pharma AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201206 -0.181 100.352 -0.214
201209 -0.119 100.467 -0.140
201212 -0.067 100.403 -0.079
201303 -0.042 100.416 -0.050
201306 -0.048 100.206 -0.057
201309 -0.006 100.544 -0.007
201312 -0.034 100.541 -0.040
201403 -0.049 99.788 -0.058
201406 -0.043 100.432 -0.051
201409 -0.026 100.161 -0.031
201412 -0.027 100.225 -0.032
201503 -0.045 99.950 -0.053
201506 -0.028 99.995 -0.033
201509 -0.025 100.228 -0.030
201512 -0.009 100.276 -0.011
201603 -0.108 100.751 -0.127
201606 -0.058 101.019 -0.068
201609 -0.012 101.138 -0.014
201612 0.009 102.022 0.010
201703 0.039 102.022 0.045
201706 0.056 102.752 0.065
201709 -0.027 103.279 -0.031
201712 -0.041 103.793 -0.047
201803 0.041 103.962 0.047
201806 0.061 104.875 0.069
201809 0.103 105.679 0.115
201812 0.018 105.912 0.020
201903 0.054 105.886 0.060
201906 0.067 106.742 0.074
201909 -0.060 107.214 -0.066
201912 -0.010 107.766 -0.011
202003 -0.448 106.563 -0.498
202006 -0.241 107.498 -0.265
202009 0.027 107.635 0.030
202012 0.031 108.296 0.034
202103 0.012 108.360 0.013
202106 -0.383 108.928 -0.416
202109 0.047 110.338 0.050
202112 0.120 112.486 0.126
202206 0.000 118.384 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Karo Pharma AB  (OTCPK:KARBF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Karo Pharma AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Karo Pharma AB (Karo Pharma AB) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22
Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Karo Pharma AB (Karo Pharma AB) Headlines

From GuruFocus

Avista Capital Partners To Sell Trimb To Karo Pharma

By PRNewswire PRNewswire 06-25-2019